Pentokey Organy (India) Ltd

PNTKYOR

Watchlist

AI Mode

‌

Market Cap

₹ 29 Cr

P/E

39.99

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

OVERVALUED

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bullish

Risk

HIGH RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Pentokey Organy (India) Ltd is primarily engaged in trading pharmaceutical-related chemical products like Acetic Acid, Ethyl Acetate, and Acetaldehyde.

Ethyl Acetate is gaining popularity as a solvent, replacing petroleum-based counterparts in various markets.

The company has strategically shifted from producing to purchasing Acetic Acid due to competitive market pricing.

Pentokey Organy expanded its production capacity of Ethanol significantly due to favorable conditions in Maharashtra.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

29 Cr

Volatility

Low Risk

P/E Ratio

40.0

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.8

52W High

63.99

52W Low

27.50

Sales CAGR

-81.14%

—

-11.94%

10Y

-40.72%

Profit CAGR

-71.59%

—

10Y

—

ROE

TTM

7.06%

15.85%

10.34%

10Y

7.83%

ROCE

TTM

7.06%

15.99%

10.43%

10Y

16.82%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MANGALAM	25.25	40 Cr	—	0.33	0.00	-15.52	-2.61	-6.25
VINEETLAB	43.08	40 Cr	—	2.79	0.00	-117.41	-22.41	-18.44
DPL	13.96	37 Cr	37.54	0.88	0.00	3.48	6.70	1.16
CBPL	41.48	31 Cr	44.13	1.04	0.00	2.04	5.91	0.70
MONOPHARMA	17.05	30 Cr	9.74	0.97	0.00	2.67	6.38	0.70
PNTKYOR	45.99	29 Cr	39.99	2.82	0.00	7.06	7.06	4.79
SUNREST	43.00	18 Cr	9.21	1.13	0.00	10.58	11.64	3.48

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	2.30	2.07	0.03	0.00	0.00	0.22	0.00	0.61	5.06	0.98
Expenses	1.97	1.83	0.10	0.07	0.08	0.26	0.07	0.63	4.62	0.95
Operating Profit	0.33	0.24	-0.07	-0.07	-0.08	-0.04	-0.07	-0.02	0.44	0.03
OPM %	14.35	11.59	-233.33	—	—	-18.18	—	-3.28	8.70	3.06
Other Income	0.11	0.11	0.11	0.12	0.13	0.15	0.10	0.08	0.04	0.11
Interest	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.43	0.36	0.04	0.05	0.05	0.11	0.04	0.06	0.48	0.14
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.43	0.36	0.04	0.05	0.05	0.11	0.04	0.06	0.48	0.14
EPS in Rs	0.68	0.57	0.06	0.08	0.07	0.17	0.06	0.09	0.99	0.23

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.77	4.70	9.29	1.56	0.00	0.00	4.37	4.40	0.83	5.89
Expenses	2.58	5.31	10	2.25	0.54	0.41	3.51	3.97	1.04	5.58
Operating Profit	-1.81	-0.61	-0.85	-0.69	-0.54	-0.41	0.85	0.43	-0.22	0.31
OPM %	-233.82	-13.03	-9.13	-43.96	-58,358.60	—	19.51	9.78	-26.17	5.26
Other Income	15	0.98	1.17	0.25	0.30	0.25	2.36	0.45	0.46	0.37
Interest	2.19	0.26	0.01	0.00	0.00	0.00	0.03	0.01	0.00	0.00
Depreciation	0.63	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	10	0.05	0.31	-0.44	-0.24	-0.16	3.18	0.87	0.25	0.69
Tax %	5.23	76.81	-1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	9.61	0.01	0.31	-0.44	-0.24	-0.16	3.18	0.87	0.25	0.69
EPS in Rs	15.32	0.01	0.50	-0.71	-0.38	-0.26	5.06	1.39	0.39	1.37
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27
Reserves	-10	-0.57	-0.55	-0.23	-0.68	-0.91	-1.07	2.11	2.99	3.18
Borrowings	18	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	6.99	3.65	0.46	0.88	0.50	0.15	0.05	0.54	0.24	0.33
Total Liabilities	21	16	6.19	6.91	6.09	5.51	5.25	8.92	9.51	9.79
Fixed Assets	10	0.12	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.01	0.02	0.01	0.02	0.02	0.03	0.04	1.24
Other Assets	11	16	6.16	6.89	6.07	5.48	5.22	8.89	9.47	8.55
Total Assets	21	16	6.19	6.91	6.09	5.51	5.25	8.92	9.51	9.79

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	12	-2.99	8.31	-1.95	0.86	0.56	-0.42	-0.10	0.55	0.22
Cash from Investing Activity	-0.19	16	-0.61	1.70	-0.89	-0.55	0.23	0.19	-0.59	-0.20
Cash from Financing Activity	-12	-13	-7.29	-0.01	0.00	0.00	0.00	-0.03	-0.01	-0.00
Net Cash Flow	-0.17	-0.23	0.42	-0.25	-0.03	0.01	-0.19	0.06	-0.04	0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%	73.03%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%	2.31%
Public	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%	24.66%
Total Shareholders	8,889	8,859	8,945	8,951	9,036	9,128	9,215	9,179	9,196	9,253	9,265	9,284

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	2.30	2.07	0.03	0.00	0.00	0.22	0.00	0.61	5.06	0.98
Expenses	1.97	1.83	0.10	0.07	0.08	0.26	0.07	0.63	4.62	0.95
Operating Profit	0.33	0.24	-0.07	-0.07	-0.08	-0.04	-0.07	-0.02	0.44	0.03
OPM %	14.35	11.59	-233.33	—	—	-18.18	—	-3.28	8.70	3.06
Other Income	0.11	0.11	0.11	0.12	0.13	0.15	0.10	0.08	0.04	0.11
Interest	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.43	0.36	0.04	0.05	0.05	0.11	0.04	0.06	0.48	0.14
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.43	0.36	0.04	0.05	0.05	0.11	0.04	0.06	0.48	0.14
EPS in Rs	0.68	0.57	0.06	0.08	0.07	0.17	0.06	0.09	0.99	0.23

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.77	4.70	9.29	1.56	0.00	0.00	4.37	4.40	0.83	5.89
Expenses	2.58	5.31	10	2.25	0.54	0.41	3.51	3.97	1.04	5.58
Operating Profit	-1.81	-0.61	-0.85	-0.69	-0.54	-0.41	0.85	0.43	-0.22	0.31
OPM %	-233.82	-13.03	-9.13	-43.96	-58,358.60	—	19.51	9.78	-26.17	5.26
Other Income	15	0.98	1.17	0.25	0.30	0.25	2.36	0.45	0.46	0.37
Interest	2.19	0.26	0.01	0.00	0.00	0.00	0.03	0.01	0.00	0.00
Depreciation	0.63	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	10	0.05	0.31	-0.44	-0.24	-0.16	3.18	0.87	0.25	0.69
Tax %	5.23	76.81	-1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	9.61	0.01	0.31	-0.44	-0.24	-0.16	3.18	0.87	0.25	0.69
EPS in Rs	15.32	0.01	0.50	-0.71	-0.38	-0.26	5.06	1.39	0.39	1.37
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27	6.27
Reserves	-10	-0.57	-0.55	-0.23	-0.68	-0.91	-1.07	2.11	2.99	3.18
Borrowings	18	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	6.99	3.65	0.46	0.88	0.50	0.15	0.05	0.54	0.24	0.33
Total Liabilities	21	16	6.19	6.91	6.09	5.51	5.25	8.92	9.51	9.79
Fixed Assets	10	0.12	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.01	0.02	0.01	0.02	0.02	0.03	0.04	1.24
Other Assets	11	16	6.16	6.89	6.07	5.48	5.22	8.89	9.47	8.55
Total Assets	21	16	6.19	6.91	6.09	5.51	5.25	8.92	9.51	9.79

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	12	-2.99	8.31	-1.95	0.86	0.56	-0.42	-0.10	0.55	0.22
Cash from Investing Activity	-0.19	16	-0.61	1.70	-0.89	-0.55	0.23	0.19	-0.59	-0.20
Cash from Financing Activity	-12	-13	-7.29	-0.01	0.00	0.00	0.00	-0.03	-0.01	-0.00
Net Cash Flow	-0.17	-0.23	0.42	-0.25	-0.03	0.01	-0.19	0.06	-0.04	0.01

Overview

Detailed Summary

Pentokey Organy (India) Ltd is primarily engaged in trading pharmaceutical-related chemical products like Acetic Acid, Ethyl Acetate, and Acetaldehyde.

Ethyl Acetate is gaining popularity as a solvent, replacing petroleum-based counterparts in various markets.

The company has strategically shifted from producing to purchasing Acetic Acid due to competitive market pricing.

Pentokey Organy expanded its production capacity of Ethanol significantly due to favorable conditions in Maharashtra.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

29 Cr

Volatility

Low Risk

P/E Ratio

40.0

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.8

52W High

63.99

52W Low

27.50

Sales CAGR

-81.14%

—

-11.94%

10Y

-40.72%

Profit CAGR

-71.59%

—

10Y

—

ROE

TTM

7.06%

15.85%

10.34%

10Y

7.83%

ROCE

TTM

7.06%

15.99%

10.43%

10Y

16.82%

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MANGALAM	25.25	40 Cr	—	0.33	0.00	-15.52	-2.61	-6.25
VINEETLAB	43.08	40 Cr	—	2.79	0.00	-117.41	-22.41	-18.44
DPL	13.96	37 Cr	37.54	0.88	0.00	3.48	6.70	1.16
CBPL	41.48	31 Cr	44.13	1.04	0.00	2.04	5.91	0.70
MONOPHARMA	17.05	30 Cr	9.74	0.97	0.00	2.67	6.38	0.70
PNTKYOR	45.99	29 Cr	39.99	2.82	0.00	7.06	7.06	4.79
SUNREST	43.00	18 Cr	9.21	1.13	0.00	10.58	11.64	3.48